Preincubation of Haemophilus influenzae with antibiotics may influence opsonophagocytosis as studied by chemiluminescence. Two strains ofH. influenzae (strain 1 [type b] and strain 2 [uncapsulated]) were pretreated with erythromycin, roxithromycin, clarithromycin, and azithromycin for 1 h in Haemophilus test medium (the last 25 min was either without serum or with 10%o fresh serum or 10%6 decomplemented serum). Human neutrophils were stimulated with a pretreated or control inoculum at four different bacterium/neutrophil ratios and tested for luminol chemiluminescence with an LKB luminometer. The results were normalized for bacterium/neutrophil ratio and compared by the two-sided Wilcoxon test. Pretreatment of bacteria with one-half of the MICs of erythromycin, clarithromycin, and roxithromycin produced nonsignificant (P > 0.05) increases in the chemiluminescence response (means of 23% for strain 1 and 4% for strain 2). Pretreatment with azithromycin at one-half of the MIC produced an increase in the chemiluminescence response induced by serum-opsonized strain 1 (320%o + 36% [mean ± standard error of the mean]) and strain 2 (107% + 20%o) (P < 0.05). This increase was concentration dependent: for strain 1, 60%o ± 18% at one-fourth of the MIC to 440% + 41% at the MIC; for strain 2, 10% ± 5% at one-fourth of the MIC to 300%o ± 20%o at the MIC. For strain 1, the maximal increase with azithromycin pretreatment (at the MIC) required opsonization with fresh serum. Opsonization with decomplemented serum was associated with a 53% + 21% increase; this increase was 28% + 3% in the absence of serum. For strain 2, azithromycin reduced the lag phase of the chemiluminescence response induced by the absence of serum but did not alter the chemiluminescence response in the presence of decomplemented serum. A significant contribution of soluble factors in the enhanced response observed with bacteria preincubated with azithromycin was excluded. The increase of the chemiluminescence response with azithromycin pretreatment was probably due to improvement in complementdependent opsonization for strain 1 and to improvement in both serum-independent and serum-dependent opsonization for strain 2.
neutrophils were stimulated with a pretreated or control inoculum at four different bacterium/neutrophil ratios and tested for luminol chemiluminescence with an LKB luminometer. The results were normalized for bacterium/neutrophil ratio and compared by the two-sided Wilcoxon test. Pretreatment of bacteria with one-half of the MICs of erythromycin, clarithromycin, and roxithromycin produced nonsignificant (P > 0.05) increases in the chemiluminescence response (means of 23% for strain 1 and 4% for strain 2). Pretreatment with azithromycin at one-half of the MIC produced an increase in the chemiluminescence response induced by serum-opsonized strain 1 (320%o + 36% [mean ± standard error of the mean]) and strain 2 (107% + 20%o) (P < 0.05). This increase was concentration dependent: for strain 1, 60%o ± 18% at one-fourth of the MIC to 440% + 41% at the MIC; for strain 2, 10% ± 5% at one-fourth of the MIC to 300%o ± 20%o at the MIC. For strain 1, the maximal increase with azithromycin pretreatment (at the MIC) required opsonization with fresh serum. Opsonization with decomplemented serum was associated with a 53% + 21% increase; this increase was 28% + 3% in the absence of serum. For strain 2, azithromycin reduced the lag phase of the chemiluminescence response induced by the absence of serum but did not alter the chemiluminescence response in the presence of decomplemented serum. A significant contribution of soluble factors in the enhanced response observed with bacteria preincubated with azithromycin was excluded. The increase of the chemiluminescence response with azithromycin pretreatment was probably due to improvement in complementdependent opsonization for strain 1 and to improvement in both serum-independent and serum-dependent opsonization for strain 2. Antimicrobial agents can interact with the host defense and in particular with the phagocytic function. Recent reviews on this subject have identified several proven or potential sites of interaction (37, 38, 40) . Pretreatment of the pathogen (e.g., with sub-MICs of P-lactams or clindamycin) can modify its handling by the professional phagocytes by altering opsonization and hence ingestion (1, 25) . Antibiotics can cause the bacteria to become more sensitive to oxygendependent or -independent killing by the phagocytes (e.g., the postantibiotic effect induced by supra-MICs of aminoglycosides and quinolones or sub-MICs of macrolides and cephalosporins) (10, 19, 27, 39) . Antibiotic pretreatment can induce the release of various bacterial substances which can activate the neutrophils directly or indirectly (e.g., priming of neutrophils) (5, 7) .
New macrolides have been developed despite the fact that their activities against Haemophilus influenzae remain low when tested in vitro, in contrast to the ,B-lactam agents. Note, however, that clinical results with macrolides for infections due to H. influenzae, such as otitis media and other upper and lower respiratory tract infections, have been comparable to those observed with ,-lactam antibiotics. Among the new macrolides, roxithromycin and clarithromy-* Corresponding author. cin are 14-member-ring macrolides (like erythromycin), and azithromycin is a 15-member-ring macrolide, more properly an azalide, with a very long half-life and exceptional tissue and intracellular penetration (6, 8, 29) . We have previously shown that 1 week after three daily doses of 500 mg of azithromycin were given to healthy volunteers, the peripheral neutrophil-associated concentration was 36.6 + 8.3 mg/liter of intracellular fluid, whereas, as expected, levels in serum were undetectable (6) . These high and prolonged cell-associated concentrations had no significant influence on chemiluminescence response induced by phorbol-12 myristate-13 acetate (PMA), opsonized zymosan, and two opsonized strains of H. influenzae (6) . In the present study, we used a luminol-enhanced chemiluminescence test, which explores the neutrophil oxidative activity, as a measure of neutrophil stimulation and phagocytosis (33) . Two strains were used, a b-capsulated strain and an uncapsulated strain of H. influenzae (the same strains as used previously [6] ). These bacteria are the major cause of meningitis (type b strain) and otitis media in children (uncapsulated strain). It has been shown previously that the lipooligosaccharide of H. influenzae induces meningeal inflammation via the triggering of cytokine secretion (including tumor necrosis factor) (24) and that subcellular bacterial components may contribute to the pathogenesis of chronic otitis media. In addition, many antibiotics, and especially the macrolides, are often present in subinhibitory concentrations at the site of these infections. Neutrophils are the first line of defense in these infections and are responsible for the containment and ultimate eradication of the offending bacteria. Our goal was to determine whether a short pretreatment of H. influenzae (1 h) with the MIC or one-half of the MIC of macrolides (erythromycin, roxithromycin, clarithromycin, and azithromycin) could modify the chemiluminescence response of the neutrophils. The effect of serum was studied by using opsonized and nonopsonized bacteria. The release of potential activators of polymorphonuclear leukocytes from antibiotic-pretreated bacteria was also investigated, since this release might enhance local inflammation and tissue damage without necessarily improving bacterial clearance. PMA (Sigma) was used as a control for neutrophil stimulation. PMA is a direct agonist of the protein-kinase C, hence the terminal phase of polymorphonuclear leukocyte activation, and does not require transmembrane signalling, in contrast to particulate stimuli such as bacteria or zymosan (34) . At the concentration used, PMA induces a maximal chemiluminescence response. Any decrease in PMA-induced chemiluminescence by the antibiotics tested would indicate an interaction with protein-kinase C and/or NADPH-oxidase activation. The medium used to dissolve PMA was similar to the bacterial inoculum medium (PBS with 10% HTM, with or without 1% serum), and it underwent the same procedure of incubation and sonication. Medium did or did not contain the test antibiotic. PMA was added just before the chemiluminescence test to a final concentration of 3 x 10-6 M.
MATERIALS
In the same medium, a nonstimulated neutrophil preparation was also tested with and without antibiotics. Each condition was tested twice.
Luminol (Janssens Chimica) was dissolved in dimethyl sulfoxide (10-2 M, stock solution). The working solution was prepared in PBS to obtain 5 x 10-' M. To each cuvette (Clinicon 2174-086; LKB-Pharmacia) was added 100 pl of luminol solution (final concentration, 5 x 10' M), 800 ,ul of stimulus solution, and 100 pl of neutrophil suspension (final concentration, 106/ml). Therefore, the highest residual concentration of the antimicrobial agent during the test was 1/25 of the MIC. After being vortexed, the cuvettes were loaded into an automatic, computer-driven luminometer (model 1251; LKB-Wallac), and chemiluminescence was measured at 425 nm every 4 min for at least 40 min.
The chemiluminescence response induced by PMA was expressed as the peak value in millivolts. The neutrophils responded immediately to PMA stimulation without a lag phase and reached a peak value within the first 12 min (Fig.  1) . The area under the concentration-time curve was linearly proportional to this peak value (not shown). The measurement of the maximal rate of increase was inaccurate with our equipment because of the absence of a lag phase. The chemiluminescence induced by H. influenzae increased gradually (Fig. 2) . A peak was not always reached within 40 min, especially at the lowest concentrations of bacteria and with nonopsonized bacteria. Moreover, the return to baseline could require several hours, and this delay is highly variable because of the clumping and decrease in neutrophil viability. The curve presented a maximal rate of increase which was proportional to the concentration of bacteria (Fig.  3) . This maximal rate of increase, which is a sensitive measure (in microvolts per minute), was therefore chosen to quantify the chemiluminescence response induced by H. influenzae. For each of the neutrophil preparations tested (from different volunteers), the relationship between the chemiluminescence response and the bacterium/neutrophil ratio was linear for the two strains studied (Fig. 3) . Therefore, the chemiluminescence response could be normalized for the bacterium/neutrophil ratio with the values obtained for the four inocula tested and could be expressed in chemiluminescence units ( Table 1 . None of the antibiotics decreased the viability of the inoculum, which contained 3 x 108 CFU/ml at the beginning of the pretreatment. In the presence of 10% fresh serum, the growth rates of the two strains were faster than those in its absence, whether or not the strain had been preincubated shortly (for 1 h) with the antibiotics.
Compared with that of the control inoculum without antibiotic, for strain 1, pretreatment of 1 h with one-half the MIC of erythromycin or clarithromycin promoted bacterial growth. On the contrary, one-half the MIC of roxithromycin or azithromycin significantly decreased the growth rate of the same strain. This effect was magnified with the MIC of azithromycin.
For strain 2, although pretreatment with one-half the MIC of erythromycin, roxithromycin, clarithromycin, or azithromycin did not alter bacterial growth, the MIC of azithromycin significantly increased the doubling time. These modifications of bacterial growth in the presence of antibiotics occurred in the same way with or without 10% serum for both strains. Chemiluminescence response induced by unstimulated neutrophils. Unstimulated neutrophils produced very little chemiluminescence, a response which did not increase significantly during the experiment (Fig. 1) plemented serum was used as the source of opsonins (Fig.  2) .
The chemiluminescence response induced by nonopsonized H. influenzae increased later than the one induced by opsonized bacteria and reached a maximal value after at least 1 h of stimulation (Fig. 2) . In addition to that prolonged lag phase (20 to 40 min), the maximal values were higher with nonopsonized than with opsonized inoculum, three-to fourfold higher for strain 1 and two-to threefold higher for strain 2.
Chemiluminescence response after stimulation with opsonized H. influenzae preincubated with one-half the MIC of macrolides. For the two strains of H. influenzae which were opsonized with fresh serum, each macrolide was tested at one-half the MIC with the neutrophils obtained from 12 different volunteers (6 for each strain). The results are shown in Table 2 for all macrolides and in Fig. 4 for azithromycin; they are expressed as the maximal rate of increase (in millivolts per minute) normalized for the bacterium/neutrophil ratio. The chemiluminescence response to untreated (Fig. 4 , closed circles). Pretreatment of the two strains for 1 h with erythromycin, roxithromycin, and clarithromycin did not alter the chemiluminescence response. Preincubation of the two strains with azithromycin significantly increased the chemiluminescence response in comparison with that of the untreated inoculum. The mean increase was 4.2-fold for the b-capsulated strain and 2.1-fold for the noncapsulated strain.
Chemiluminescence response after stimulation with opsonized H. influenzae preincubated with various concentrations of azithromycin. The increase in the chemiluminescence response induced by fresh serum-opsonized H. influenzae was proportional to the concentration of azithromycin for both strains (Fig. 5) . At twice the MIC of azithromycin, the viable count of strain 1 (but not that of strain 2) decreased so that the relationship between chemiluminescence response and bacterial inoculum was artifactually shifted to the left. Therefore, we corrected for the total inoculum (living and dead bacterial cells) by using the initial viable count measured just before the addition of azithromycin (Fig. 5) corrected curve could be superimposed exactly on the curve obtained with the MIC, suggesting that the response was produced by the total number of bacterial cells and not by potentially active substances released by the bacteria as a consequence of azithromycin pretreatment.
Chemiluminescence response induced by H. influenzae preincubated with MIC of azithromycin. To understand by which mechanism pretreatment of azithromycin increased the neutrophil chemiluminescence response, no opsonization or opsonization with decomplemented serum was compared with fresh serum opsonization after a 1-h preincubation at the MIC of azithromycin (Fig. 2) . For each condition, three different bacterium/neutrophil ratios were tested in duplicate with the neutrophils of a single volunteer. For strain 1, azithromycin pretreatment did not alter the shape of the chemiluminescence response in comparison with that by untreated bacteria. Under each condition of opsonization, azithromycin pretreatment increased chemiluminescence peak values and the maximal rate of increase, but the highest level of enhancement was measured when the bacteria were opsonized with fresh serum. The percentage of increase compared with that by the untreated inoculum was 28% ± 3% in the absence of serum and 72% + 29% with fresh serum in the first experiment (volunteer A) and 53% ± 21% with decomplemented serum and 143% ± 1% with fresh serum in the second experiment (volunteer B).
For strain 2, azithromycin pretreatment did not alter the chemiluminescence response in the presence of decomplemented serum (volunteer D) (Fig. 2) . Azithromycin pretreatment strongly reduced the lag phase of the chemiluminescence curves obtained with nonopsonized bacteria. On the other hand, the percentage of increase was higher with fresh serum (221% ± 56%) than without serum (46% ± 23%).
Chemiluminescence response induced by the filtrate of nonopsonized H. influenzae suspension pretreated with the MIC of azithromycin. Filtrates of nonopsonized inocula were tested as stimuli for neutrophil chemiluminescence. For the two strains, filtrates with or without serum induced very little chemiluminescence, a response which was at least 10x lower than the response induced by whole bacteria (data not shown). These responses were only marginally increased with azithromycin pretreatment (at the MIC). This excluded the significant contribution of soluble factors in the enhanced response associated with azithromycin preincubation. 
DISCUSSION
The effects on several functions of the neutrophils of preincubating bacteria with sub-MICs have been studied with 1-lactam antibiotics, macrolides, clindamycin, aminoglycosides, and fluoroquinolones against various bacteria, including gram-positive and -negative species (37, 38) . In most studies, the duration of preincubation was prolonged (typically overnight), allowing the possible selection of a subpopulation present at a low number in the initial'population and expressing a phenotype different from that of the majority of the bacterial cells rather than a modification of the whole initial population. The phenotypic modifications reported previously include an opsonin requirement (43, 44) , the loss of an external barrier (protein M, capsule, or protein A) (11, 13, 16, 28, 31) , the presence of pili (42) , the type of lipopolysaccharide or its geometry (20) , and the expression of toxins (4) .
We have shown that very short pretreatment (1 h) of H. influenzae with sub-MICs of azithromycin (a 15-membered macrolide or azalide-macrolide) increased the chemiluminescence response of human peripheral neutrophils obtained from 18 different human volunteers. This was not observed with three other macrolides, i.e., erythromycin, roxithromycin, and clarithromycin (all 14-membered-ring macrolides) (17); we did not test 14-hydroxyclarithromycin, the major and bioactive metabolite of clarithromycin (12, 14) , which was not available to us. The reason for such a discrepancy between the azalide azithromycin and the other macrolides is still unclear. It may be related to the much higher intrinsic activity of azithromycin against H. influenzae (9). This might be due to faster bacterial uptake or affinity to the ribosome, although no such data have been published yet for the azalide class of macrolides (29) . Direct interaction with neutrophils was excluded from the present study as well as our previous report (6) . The largest effect associated with azithromycin was observed with the b-capsulated strain of H. influenzae opsonized with fresh human pooled sera. The enhancement of the chemiluminescence response was dose dependent, with a plateau at the MIC. A concentration of twice the MIC did not increase the chemiluminescence response further when all bacterial cells (living and dead) were taken into account. An attempt to modelize the relationship was performed (Fig. 6 ) with the ratio of the chemiluminescence responses of the preincubated inoculum to those of the untreated inoculum (AB/T ratio). This clearly suggested that with additional test points, a reasonably sigmoidEma model could probably fit the data, as expected. Maximal effect (Ema) would probably be similar for the two strains, close to a 400% increase of the response obtained with the untreated inoculum. The filtrate of pretreated bacterial cells increased only marginally the response induced by the filtrate of untreated bacteria, which was already very low in comparison with the response induced by nonopsonized bacteria. This suggests that the contribution of soluble factors released from pretreated bacteria was very low. This could also rule out an indirect effect due to monocyte stimulation by soluble factors. Several antimicrobial agents have been previously shown to induce the release of lipopolysaccharides from gram-negative bacilli (7, 32) . It has been shown previously that in meningitis due to gram-negative bacilli and b-capsulated H. influenzae, a very large release of lipopolysaccharides, eventually associated with antibiotics, was responsible for a more intense release of cytokines, more severe inflammation, and hence a poorer prognosis (21, 22, 24, 35, 36, 45) . H. influenzae lipopolysaccharide has recently been shown to disrupt confluent monolayers of endothelial brain cells via a serum-dependent cytotoxic pathway (26) . Similar findings were reported with Streptococcus pneumoniae in an experimental model of meningitis in rabbits (36) .
As far as the mechanism for enhanced neutrophil response is concerned, our results obtained without and with opsonization (with fresh or decomplemented serum) suggest that the enhanced chemiluminescence response induced by azithromycin was associated with increased ingestion probably due to better complement-dependent opsonization of the capsulated strain through better spatial availability of C3b molecule disposition. This hypothesis is currently under investigation, first with radiolabelled bacteria and direct measurement of ingestion and second with radiolabelled C3.
Preincubation of the uncapsulated strain of H. influenzae with sub-MICs of azithromycin also increased the chemiluminescence response of neutrophils. This was observed with both opsonized and nonopsonized bacteria. Improved ingestion could also be the mechanism for such an enhanced chemiluminescence response, but because of serum-independent factors, this ingestion was probably lectin dependent.
Noncapsulated strains of H. influenzae are responsible for otitis media in children and lower and upper respiratory tract infections in adults that are occasionally associated with bacteremias. The release of lipooligosaccharides from H. influenzae might also contribute to local inflammation and sequelae, as for meningitis. Such an effect by a wall component has been shown for S. pneumoniae in an experimental model of otitis media (30) . In infectious sites such as the sinuses and the middle ear, concentrations of most macrolides (including azithromycin) are usually below the MICs for H. influenzae (18) . The effects reported here might explain the good clinical successes observed with azithromycin through enhancement of phagocytosis and possibly intracellular killing. The effect of azithromycin preincubation on intracellular killing by human neutrophils is currently under investigation in our laboratory.
Despite the large number of published articles about the interaction between antibiotics and phagocytosis, few of these have addressed the significance of the variability of response between volunteers and the source of the neutrophils tested (for a discussion, see references 40 and 41) . Further studies to explain the mechanism of such variability are needed.
The clinical consequences of our observations are difficult to assess. However, in the sinuses, the middle ear, and the respiratory tract, sub-MICs of antimicrobial agents are usually present after a usual dosage. A good clinical response despite a low antimicrobial concentration might therefore be explained by an increased neutrophil response. On the other hand, overstimulation of the neutrophils could be associated with more tissue damage due to the release of potent oxidants, proteolytic enzymes, and chemoattractants for both neutrophils and monocytes.
